High-circulating Myeloid-derived Suppressor Cells (Part H)
1 clinical trials · Condition
◉ Watch High-circulating Myeloid-derived Suppressor Cells (Part H)
| Record | Firm | Date |
|---|---|---|
| A Dose-Escalation Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of IPI-549 (NCT02637531) | Infinity Pharmaceuticals, Inc. | 2015-12-01 |
Track High-circulating Myeloid-derived Suppressor Cells (Part H) automatically
Every clearance here is in the API, with alerts when new ones post.